Latest Industry Insights

We spoke to Tom Harrison, Business Development Manager, TTP Ventus, to learn more about the technology behind Disc Pump, and some of the applications it could benefit.

Dr Keri Donaldson, CEO and founder of predictive health intelligence company Prescient Medicine, tells us about the role that genetic testing could play in tackling the opioid crisis.

BioStatus develops and supplies products for cell-based imaging, cytometry and screening applications. We met with Roy Edward, Director at BioStatus during the High Content and Phenotypic Screening 2017 event to learn more.

Bacterial resistance to antibiotics is a growing concern, and is no less prevalent among pathogens causing sexually transmitted infections. Colin Denver tells us about the success of a multiplex diagnostics approach in testing azithromycin resistance in Mycoplasma genitalium.

As pharmaceutical supply chains have grown in complexity the data used by drug developers and manufacturers to make decisions is coming under greater scrutiny from regulatory authorities.

To learn more about the challenges researchers currently face and how the iCAP™ TQ ICP-MS instrument helps provide better quality data from challenging samples, we spoke to Dr Daniel Kutscher, Product Specialist, ICP-MS Trace Element Analysis, Thermo Fisher Scientific.

Researchers test new amplifier compound to treat Cystic Fibrosis and also develop better tools for drug discovery.

Dr Paul Colborn, CEO of University of Liverpool spin-out company, ChiroChem Ltd, talks about the growing company's big plans.

Across the industry, the most efficient and secure food chain workflows are adopting laboratory information management systems (LIMS) to securely store, manage and access the vast amounts of data associated with food safety testing.

We spoke to Barbara Fallowfield to learn about the test, the benefits it can offer patients, and the role that point-of-care tests may play in the future of healthcare.